Diferencia entre revisiones de «Diabetic foot infection»
Sin resumen de edición |
|||
| Línea 1: | Línea 1: | ||
<h2>Background</h2> | |||
<ul><li>1st key factor is to assess extent & depth of ulcer (typically more extensive than they appear) | |||
<ul><li>Ulcer depth is important predictor of healing rate, osteomyelitis (OM) & risk of amputation. | |||
</li></ul> | |||
</li><li>Failure of ulcer to heal by 50% or more after 1 month of Rx is a strong predictor that the ulcer is unlikely to heal after 3 mos. | |||
</li><li>75% of pts hv polymicrobial inf, usu 70% are g+. Severe limb/life threatening inf are more likely to involve g- aerobic & anaerobic bacteria w/ g+. MRSA is incr in freq. | |||
</li><li>50% or more of pts w/ SEVERE diabetic foot inf have no s/s of systemic tox (ie fever, tachy, incr wbc or Lt shift) | |||
</li></ul> | |||
<h2>HPI</h2> | |||
<ul><li>Ask about recent trauma | |||
</li><li>Duration of current lesions | |||
</li><li>Associated systemic symptoms | |||
</li><li>Prior treatments | |||
</li></ul> | |||
<h2>Physical Exam</h2> | |||
<ul><li>Determine ulcer location, dimensions, depth, and appearance | |||
</li><li>Note hair and nail growth, determine vascular status (palpate DP, PT, and popliteal pulse) | |||
</li><li>Probe ulceration note involvement of bone, joint, tendon, or sinus tract formation | |||
<ul><li>Use sterile probe, if hit bone chance of OM 90% higher | |||
</li></ul> | |||
</li><li>DM foot ulcer infection presumed if: | |||
<ul><li>2 or more of following: erythema, warmth, tenderness, or swelling | |||
</li><li>OR if pus coming from ulcer site or nearby sinus tract | |||
</li></ul> | |||
</li><li>Severe DM foot infection if: | |||
<ul><li>abnormal vital signs | |||
</li><li>Rim of erythema surrounding ulcer or ulcer >2 cm in diameter | |||
</li><li>Lymphangitic streaking or signs of fasciitis (crepitus, skip lesions, severe TTP, bullae), or if probe reaches bone/joint/tendon | |||
</li></ul> | |||
</li><li>Obtain ABI on all patients with: nonpalpable DP/PT, claudication sx, ischemic foot pain | |||
<ul><li>Call vascular if: | |||
<ul><li>ABI <0.4 (severe obstruction) | |||
</li><li>ABI 0.4-0.69 (mod obstruction) | |||
</li></ul> | |||
Determine presence/extent of infection and likelihood of OM/fasciitis | </li></ul> | ||
</li><li>Reminder: | |||
<ul><li>DM ulcers usually occur at areas of increased pressure (sole of foot) or friction | |||
</li><li>Venous ulcers usually present above malleoli with irregular borders | |||
</li><li>Arterial ulcers usually found on the toes or shins, with pale, "punched-out" borders (typically painful) | |||
</li></ul> | |||
</li></ul> | |||
<h2>Diagnosis</h2> | |||
<p>Determine presence/extent of infection and likelihood of OM/fasciitis | |||
</p> | |||
<h3>Imaging</h3> | |||
<ul><li>X-rays to detect soft tissue gas, FB, OM, or structural foot deformities | |||
<ul><li>OM x-ray changes occur late in dz, negative xrays do not exclude OM | |||
</li></ul> | |||
</li><li>MRI to eval for OM (not usually done in ED) | |||
</li></ul> | |||
<h3>Labs</h3> | |||
<ul><li>Chem 10, CBC, Coags, A1c, consider ESR/CRP (useful for monitoring response to Rx) | |||
</li><li>ESR >40 incr chance of OM 12 fold, an ESR >70 makes dx nearly certain. | |||
</li></ul> | |||
<h3>Likelihood of OM</h3> | |||
<ul><li>Factors that increase likelihood of OM: | |||
<ul><li>Visible bone or probe to bone | |||
</li><li>Ulcer > 2cm in size | |||
</li><li>ESR >70 | |||
</li><li>Ulcer duration > 2 weeks | |||
</li></ul> | |||
</li></ul> | |||
<h2>Treatment</h2> | |||
<ul><li>For noninfected chronic wounds | |||
<ul><li>NWB, nonadherent padded dressing, ppx abx not indcated | |||
</li></ul> | |||
</li><li>For infected DM foot ulcers @ HUCLA: | |||
<ul><li>Start pt on <b>Diabetic Foot Infection with Wound (DFIW)</b> pathway/order set <b>(No ABX)</b> | |||
<ul><li>Do not start pts on this pathway if have rapidly spreading infection or with severe sepsis/septic shock | |||
</li></ul> | |||
</li><li>Primary management is surgical debridement, consult trauma surgery | |||
</li></ul> | |||
</li><li>Empiric therapy for DM foot infections: | |||
<ul><li>Mild infxn outpt Rx, non-limb-threatening (MSSA + strep): | |||
<ul><li><b>Keflex</b> 500mg Q6H OR <b>Augmentin</b> 875/125mg Q12H OR <b>Dicloxacillin</b> 500mg Q6H OR <b>Clinda</b> 450mg Q8H | |||
</li><li>Strict NWB, tight glycemic control, meticulous wound care | |||
</li></ul> | |||
</li><li>Severe infxn, limb-threatening (admit): | |||
</li><li><b>Unasyn</b> 3g IV Q6H OR <b>Ticarcillin-clavulanate</b> 3.1g IV Q8H OR <b>Clinda</b> 900mg IV Q6H AND <b>Ciprofloxacin</b> 400mg IV Q12H OR <b>Clinda</b> 900mg IV Q6H and <b>Ceftriaxone</b> 1g IV Q12H add vanco if life threat. | |||
</li></ul> | |||
</li></ul> | |||
<ol><li>Recurrence of amp is 50-70% over 3-5 yrs. Overall, 50-80% will heal w/in 6 mos w/ optimal care. | |||
</li><li>Goal for best reults is A1c level <7%, BP <130/80, no Etoh or smoking & LDL <100. | |||
</li></ol> | |||
<h2>Source</h2> | |||
<ul><li>Tintinalli | |||
</li><li>UpToDate | |||
</li><li>PANI | |||
</li></ul> | |||
<a _fcknotitle="true" href="Category:ID">ID</a> | |||
Revisión del 22:45 23 ago 2013
Background
- 1st key factor is to assess extent & depth of ulcer (typically more extensive than they appear)
- Ulcer depth is important predictor of healing rate, osteomyelitis (OM) & risk of amputation.
- Failure of ulcer to heal by 50% or more after 1 month of Rx is a strong predictor that the ulcer is unlikely to heal after 3 mos.
- 75% of pts hv polymicrobial inf, usu 70% are g+. Severe limb/life threatening inf are more likely to involve g- aerobic & anaerobic bacteria w/ g+. MRSA is incr in freq.
- 50% or more of pts w/ SEVERE diabetic foot inf have no s/s of systemic tox (ie fever, tachy, incr wbc or Lt shift)
HPI
- Ask about recent trauma
- Duration of current lesions
- Associated systemic symptoms
- Prior treatments
Physical Exam
- Determine ulcer location, dimensions, depth, and appearance
- Note hair and nail growth, determine vascular status (palpate DP, PT, and popliteal pulse)
- Probe ulceration note involvement of bone, joint, tendon, or sinus tract formation
- Use sterile probe, if hit bone chance of OM 90% higher
- DM foot ulcer infection presumed if:
- 2 or more of following: erythema, warmth, tenderness, or swelling
- OR if pus coming from ulcer site or nearby sinus tract
- Severe DM foot infection if:
- abnormal vital signs
- Rim of erythema surrounding ulcer or ulcer >2 cm in diameter
- Lymphangitic streaking or signs of fasciitis (crepitus, skip lesions, severe TTP, bullae), or if probe reaches bone/joint/tendon
- Obtain ABI on all patients with: nonpalpable DP/PT, claudication sx, ischemic foot pain
- Call vascular if:
- ABI <0.4 (severe obstruction)
- ABI 0.4-0.69 (mod obstruction)
- Call vascular if:
- Reminder:
- DM ulcers usually occur at areas of increased pressure (sole of foot) or friction
- Venous ulcers usually present above malleoli with irregular borders
- Arterial ulcers usually found on the toes or shins, with pale, "punched-out" borders (typically painful)
Diagnosis
Determine presence/extent of infection and likelihood of OM/fasciitis
Imaging
- X-rays to detect soft tissue gas, FB, OM, or structural foot deformities
- OM x-ray changes occur late in dz, negative xrays do not exclude OM
- MRI to eval for OM (not usually done in ED)
Labs
- Chem 10, CBC, Coags, A1c, consider ESR/CRP (useful for monitoring response to Rx)
- ESR >40 incr chance of OM 12 fold, an ESR >70 makes dx nearly certain.
Likelihood of OM
- Factors that increase likelihood of OM:
- Visible bone or probe to bone
- Ulcer > 2cm in size
- ESR >70
- Ulcer duration > 2 weeks
Treatment
- For noninfected chronic wounds
- NWB, nonadherent padded dressing, ppx abx not indcated
- For infected DM foot ulcers @ HUCLA:
- Start pt on Diabetic Foot Infection with Wound (DFIW) pathway/order set (No ABX)
- Do not start pts on this pathway if have rapidly spreading infection or with severe sepsis/septic shock
- Primary management is surgical debridement, consult trauma surgery
- Start pt on Diabetic Foot Infection with Wound (DFIW) pathway/order set (No ABX)
- Empiric therapy for DM foot infections:
- Mild infxn outpt Rx, non-limb-threatening (MSSA + strep):
- Keflex 500mg Q6H OR Augmentin 875/125mg Q12H OR Dicloxacillin 500mg Q6H OR Clinda 450mg Q8H
- Strict NWB, tight glycemic control, meticulous wound care
- Severe infxn, limb-threatening (admit):
- Unasyn 3g IV Q6H OR Ticarcillin-clavulanate 3.1g IV Q8H OR Clinda 900mg IV Q6H AND Ciprofloxacin 400mg IV Q12H OR Clinda 900mg IV Q6H and Ceftriaxone 1g IV Q12H add vanco if life threat.
- Mild infxn outpt Rx, non-limb-threatening (MSSA + strep):
- Recurrence of amp is 50-70% over 3-5 yrs. Overall, 50-80% will heal w/in 6 mos w/ optimal care.
- Goal for best reults is A1c level <7%, BP <130/80, no Etoh or smoking & LDL <100.
Source
- Tintinalli
- UpToDate
- PANI
<a _fcknotitle="true" href="Category:ID">ID</a>
